As higher MCP-1 levels were associated with worse disease severity and faster progression by several authors [21], and due to the HERV-K related lower expression of this chemokine documented in our study, it is likely to work together with the increased expression of MIP-1α to produce a better ALS outcome. This evidence concerns the gene CCL3 and amyotrophic lateral sclerosis.